NDC 51655-964
Clindamycin hydrochloride 150 mg capsule
On the label: Northwind Pharmaceuticals. It's repackaged: Northwind Pharmaceuticals rebottles it from Caraco Pharmaceutical Laboratories, Ltd.'s NDC 63304-692.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Ohm Laboratories Inc. | North Brunswick, NJ, United States | Makes it | No problems foundOct 31, 2024 · 22 inspections |
| Sun Pharmaceutical Industries Limited | Halol, India | Makes it | Serious problems, FDA actionJun 13, 2025 · 12 inspections, 5 with FDA action |
Repackaging site
- Northwind Health Company, LLC, Indianapolis, IN, United States · repackages it
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: AB77104
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- capsule, oral
- Strength
- 150 mg
- Approval
- ANDA ANDA065061
- On the market since
- Mar 13, 2023
- Package NDCs
51655-964-2151655-964-51- Official label
- DailyMed (National Library of Medicine), updated Jan 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?